Trial Profile

Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 03 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Samarium 153 lexidronam (Primary) ; Calcium; Strontium-89; Vitamin D analogues; Zoledronic acid
Indications Advanced breast cancer; Bone metastases; Lung cancer; Prostate cancer
Focus Registrational; Therapeutic Use

Most Recent Events

03 Apr 2018 Status changed from active, no longer recruiting to completed.
01 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
30 Jun 2009 Additional lead trial investigators identified as reported by New Jersey Cancer Trial Connect.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com